Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan Yee Lau

Showing results (231-240 of 395) with videos related to

Pageof 40
Sort By:
JAMA Surgery|August 4, 2018
Association of Preoperative Antiviral Treatment With Incidences of Microvascular Invasion and Early Tumor Recurrence in Hepatitis B Virus-Related Hepatocellular CarcinomaZheng Li, Zhengqing Lei, Yong Xia, et al.
Plos One|October 11, 2014
CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinomaLi Li, Jing Yan, Jing Xu, et al.
Therapeutic Advances in Gastroenterology|December 17, 2020
Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysisLei Liang, Chao Li, Yong-Kang Diao, et al.
Cancer Management and Research|October 29, 2020
Preoperative Inversed Albumin-to-Globulin Ratio Predicts Worse Oncologic Prognosis Following Curative Hepatectomy for Hepatocellular CarcinomaCheng-Cheng Zhang, Cheng-Wu Zhang, Hao Xing, et al.
Liver Cancer|August 8, 2024
A Prospective, Single-Arm, Phase 2 Study of Modified Transarterial Chemoembolization Using Low-Dose Chemotherapy with Blank Microspheres Plus Low-Dose Lenvatinib and Microwave Ablation in Patients with Large (≥7 cm) Unresectable Hepatocellular Carcinoma: The TALEM TrialZhi-Mei Huang, Xue Han, Jian Wang, et al.
Hepatobiliary Surgery and Nutrition|October 21, 2022
One- versus two-stage partial hepatectomy for large resectable solitary hepatocellular carcinomas determined preoperatively to have a narrow resection margin: a propensity score matching analysisYao Li, Peng-Peng Li, Da-Peng Sun, et al.
International Journal of Surgery (London, England)|June 6, 2022
Clinical consensus statement: Selective internal radiation therapy with yttrium 90 resin microspheres for hepatocellular carcinoma in AsiaDavid M Liu, Thomas Wt Leung, Pierce Kh Chow, et al.
International Journal of Surgery (London, England)|February 8, 2024
Watch-and-wait strategy vs. resection in patients with radiologic complete response after conversion therapy for initially unresectable hepatocellular carcinoma: a propensity score-matching comparative studyBinkui Li, Chenwei Wang, Wei He, et al.
Annals of Surgery|January 26, 2022
A Prospective Study Using Propensity Score Matching to Compare Long-term Survival Outcomes After Robotic-assisted, Laparoscopic, or Open Liver Resection for Patients With BCLC Stage 0-A Hepatocellular CarcinomaPeng Zhu, Wei Liao, Wan-Guang Zhang, et al.
Journal of Clinical Epidemiology|June 29, 2015
Reporting and methodological qualities of published surgical meta-analysesHan Zhang, Jun Han, Ying-Bo Zhu, et al.
Pageof 40

Showing results (231-240 of 395) with videos related to

Sort By:
Pageof 40
JAMA Surgery|August 4, 2018
Association of Preoperative Antiviral Treatment With Incidences of Microvascular Invasion and Early Tumor Recurrence in Hepatitis B Virus-Related Hepatocellular CarcinomaZheng Li, Zhengqing Lei, Yong Xia, et al.
Plos One|October 11, 2014
CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinomaLi Li, Jing Yan, Jing Xu, et al.
Therapeutic Advances in Gastroenterology|December 17, 2020
Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysisLei Liang, Chao Li, Yong-Kang Diao, et al.
Cancer Management and Research|October 29, 2020
Preoperative Inversed Albumin-to-Globulin Ratio Predicts Worse Oncologic Prognosis Following Curative Hepatectomy for Hepatocellular CarcinomaCheng-Cheng Zhang, Cheng-Wu Zhang, Hao Xing, et al.
Liver Cancer|August 8, 2024
A Prospective, Single-Arm, Phase 2 Study of Modified Transarterial Chemoembolization Using Low-Dose Chemotherapy with Blank Microspheres Plus Low-Dose Lenvatinib and Microwave Ablation in Patients with Large (≥7 cm) Unresectable Hepatocellular Carcinoma: The TALEM TrialZhi-Mei Huang, Xue Han, Jian Wang, et al.
Hepatobiliary Surgery and Nutrition|October 21, 2022
One- versus two-stage partial hepatectomy for large resectable solitary hepatocellular carcinomas determined preoperatively to have a narrow resection margin: a propensity score matching analysisYao Li, Peng-Peng Li, Da-Peng Sun, et al.
International Journal of Surgery (London, England)|June 6, 2022
Clinical consensus statement: Selective internal radiation therapy with yttrium 90 resin microspheres for hepatocellular carcinoma in AsiaDavid M Liu, Thomas Wt Leung, Pierce Kh Chow, et al.
International Journal of Surgery (London, England)|February 8, 2024
Watch-and-wait strategy vs. resection in patients with radiologic complete response after conversion therapy for initially unresectable hepatocellular carcinoma: a propensity score-matching comparative studyBinkui Li, Chenwei Wang, Wei He, et al.
Annals of Surgery|January 26, 2022
A Prospective Study Using Propensity Score Matching to Compare Long-term Survival Outcomes After Robotic-assisted, Laparoscopic, or Open Liver Resection for Patients With BCLC Stage 0-A Hepatocellular CarcinomaPeng Zhu, Wei Liao, Wan-Guang Zhang, et al.
Journal of Clinical Epidemiology|June 29, 2015
Reporting and methodological qualities of published surgical meta-analysesHan Zhang, Jun Han, Ying-Bo Zhu, et al.
Pageof 40